ANTIPHOSPHOLIPID SYNDROME COLLABORATIVE REGISTRY

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 目的：建立全国抗磷脂综合征(APS)登记系统。该登记处将收集和更新临床、人口学数据，并更新有关APS患者和抗磷脂抗体无症状患者的临床、人口学和实验室数据。 研究计划和方法：在这项为期5年的研究中，8个地点每个地点预计每年招收50名患者。参与者将接受约30-45分钟的采访，以了解有关APS的病史和特征的详细信息。将采集并储存血液样本，以确认抗磷脂抗体的存在。一旦参与者被批准注册，就可以就未来涉及注册的研究与他们联系。参与者没有义务参与这些研究。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. OBJECTIVE: The purpose of this study is to establish a national registry for Antiphospholipid Syndrome (APS). The registry will collect and update clinical, demographic, and update clinical, demographic, and laboratory data on individuals with APS and asymptomatic patients with antiphospholipid antibodies. RESEARCH PLAN AND METHODS: Each of the eight sites are expected to enroll 50 patients per year of the 5-year study. Participants will be interviewed for approximately 30-45 minutes to get detailed information about medical history and features of APS. A blood sample will be obtained and stored for confirmation of the presence of antiphospholipid antibodies. Once the participant has been approved for enrollment they may be contacted about future studies involving the registry. Participants are under no obligation to participate in these studies.